LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer.
Li M, Viswanadhapalli S, Santhamma B, Pratap UP, Luo Y, Liu J, Altwegg KA, Tang W, Liu Z, Li X, Ebrahimi B, Yan H, Zou Y, Konda S, Sareddy GR, Xu Z, Chen Y, Rao MK, Brenner AJ, Kaklamani VG, Tekmal RR, Ahmed G, Raj GV, Nickisch KJ, Nair HB, Vadlamudi RK.
Li M, et al. Among authors: brenner aj.
Commun Biol. 2021 Oct 29;4(1):1235. doi: 10.1038/s42003-021-02741-7.
Commun Biol. 2021.
PMID: 34716410
Free PMC article.